186 related articles for article (PubMed ID: 9502172)
21. Ranitidine and other H2-receptor antagonists: recent developments.
Daly MJ; Price BJ
Prog Med Chem; 1983; 20():337-68. PubMed ID: 6138817
[No Abstract] [Full Text] [Related]
22. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
[TBL] [Abstract][Full Text] [Related]
23. In vitro actions of ranitidine, a new histamine H2-receptor antagonist.
Daly MJ; Stables R
Agents Actions; 1980 Apr; 10(1 Pt 2):190-1. PubMed ID: 6104417
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological studies of 2-(3-(3-(1-piperidinylmethyl)-phenoxy)propylamino)-4 (3H)-quinazolinone (NO-794), a new histamine H2-receptor antagonist.
Oshita M; Morikawa K; Aratani T; Kato H; Ito Y
Jpn J Pharmacol; 1986 Oct; 42(2):229-35. PubMed ID: 2879057
[TBL] [Abstract][Full Text] [Related]
25. Pharmacology of mifentidine, a novel H2-receptor antagonist.
Pagani F; Micheletti R; Brambilla A; Schiavone A; Montagna E; Ciprandi C; Giachetti A
Arzneimittelforschung; 1985; 35(1A):451-5. PubMed ID: 2859036
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological analysis of the CCKB/gastrin receptors mediating pentagastrin-stimulated gastric acid secretion in the isolated stomach of the immature rat.
Hills DM; Gerskowitch VP; Roberts SP; Welsh NJ; Shankley NP; Black JW
Br J Pharmacol; 1996 Dec; 119(7):1401-10. PubMed ID: 8968549
[TBL] [Abstract][Full Text] [Related]
27. Antisecretory effects of a novel and long-lasting histamine H2-receptor antagonist, YM-14471, in rats and dogs.
Yuki H; Kamato T; Nishida A; Fujihara A; Takeda M; Miyata K
Jpn J Pharmacol; 1993 Nov; 63(3):345-51. PubMed ID: 7906319
[TBL] [Abstract][Full Text] [Related]
28. The antisecretory profile of action of the H2-receptor antagonists, famotidine, loxtidine, ranitidine and L-643,441 on the rat isolated gastric mucosa.
Reeves JJ; Stables R
Agents Actions; 1987 Feb; 20(1-2):22-8. PubMed ID: 2883848
[TBL] [Abstract][Full Text] [Related]
29. The new histamine H2-receptor antagonist ranitidine. Duration of action.
Dammann HG; Simon B
Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781
[TBL] [Abstract][Full Text] [Related]
30. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
[TBL] [Abstract][Full Text] [Related]
31. H2-receptor antagonist and gastric acid antisecretory properties of Wy-45,662.
Nielsen ST
Agents Actions; 1986 Nov; 19(3-4):158-63. PubMed ID: 2881454
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of gastric acid inhibition by ranitidine in duodenal ulcer patients.
Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
Digestion; 1981; 22(3):119-25. PubMed ID: 6116636
[TBL] [Abstract][Full Text] [Related]
33. Antagonism of vasodepressor and gastric secretory responses to histamine by the H2-receptor antagonists, ranitidine and cimetidine, in the anaesthetized dog.
Daly MJ; Humphray JM; Stables R
Br J Pharmacol; 1981 Jan; 72(1):55-60. PubMed ID: 6112035
[TBL] [Abstract][Full Text] [Related]
34. Induction of gastric histamine synthesis by H2-receptor antagonists: potentiation of their antisecretory activity by histidine decarboxylase inhibitors.
Huszti Z; Pik K; Frenkl R
Agents Actions; 1980 Sep; 10(4):302-8. PubMed ID: 6108701
[TBL] [Abstract][Full Text] [Related]
35. Effect of BMY-25368, a potent and long-acting histamine H2-receptor antagonist, on gastric secretion and aspirin-induced gastric lesions in the dog.
Cavanagh RL; Buyniski JP
Aliment Pharmacol Ther; 1989 Jun; 3(3):299-313. PubMed ID: 2577694
[TBL] [Abstract][Full Text] [Related]
36. Histamine H2-receptor blocking activity of ranitidine and lamtidine analogues containing aminomethyl-substituted aliphatic systems.
Orsetti M
Agents Actions; 1988 Dec; 25(3-4):291-5. PubMed ID: 2905866
[TBL] [Abstract][Full Text] [Related]
37. [Effects of IGN-2098, a new histamine H2-receptor antagonist, on gastric secretion and gastric and duodenal lesions induced in rats. Comparison with roxatidine].
Okabe S; Narita M; Nakaji S; Takinami Y; Kawano O; Misaki N
Nihon Yakurigaku Zasshi; 1992 Mar; 99(3):167-80. PubMed ID: 1354631
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological profile of a new peptidic gastrin antagonist.
Lavezzo A; Bali JP; Magous R; Lignon MF; Nisato D; Laur J; Castro B; Martinez J
Regul Pept; 1986 Sep; 15(2):111-9. PubMed ID: 3786833
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of action of H2-antagonists on histamine- or dimaprit-stimulated H2-receptors of spontaneously beating guinea-pig atrium.
Krielaart MJ; Veenstra DM; van Buuren KJ
Agents Actions; 1990 Aug; 31(1-2):23-35. PubMed ID: 1704683
[TBL] [Abstract][Full Text] [Related]
40. Gastric ECL-cell hyperplasia produces enhanced basal and stimulated gastric acid output but not gastric erosion formation in the rat.
LePard KJ; Mohammed JR; Stephens RL
Gen Pharmacol; 1997 Mar; 28(3):415-20. PubMed ID: 9068983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]